At what age is ampicillin (Ampicillin) used to cover meningitis?

From the Guidelines

Ampicillin is used to cover meningitis in neonates less than 1 month old, and its use may be extended to infants up to 3 months of age in certain cases, particularly when Listeria monocytogenes is a concern. When considering the use of ampicillin for meningitis coverage, it's crucial to take into account the patient's age and the potential pathogens involved.

• For neonates under 1 month old, ampicillin is recommended in combination with other antibiotics such as cefotaxime or an aminoglycoside, as outlined in the escmid guideline for the diagnosis and treatment of acute bacterial meningitis 1.
• The dosage of ampicillin for neonates less than 1 week old is typically 50 mg/kg every 8 hours, and for those 1-4 weeks old, it's 50 mg/kg every 6 hours, as specified in the guideline 1.
• For infants older than 1 month but less than 3 months, the use of ampicillin may be considered, especially if there's a risk of Listeria monocytogenes infection, with recommendations including ampicillin with an aminoglycoside for those up to 7 days old, and broader-spectrum therapy for those at higher risk or with signs of severe illness 1. Key points to consider include:
• The combination of ampicillin with other antibiotics is necessary to cover a broad range of potential pathogens, including Listeria monocytogenes and Group B Streptococcus, which are common in young infants but not adequately covered by cephalosporins alone.
• The choice of antibiotic regimen should be guided by the patient's age, clinical presentation, and local epidemiology of bacterial meningitis.
• The most recent and highest quality evidence, such as the 2016 escmid guideline 1 and the 2020 AAP updates for the management of at-risk infants 1, should inform clinical decision-making regarding the use of ampicillin for meningitis coverage.

From the FDA Drug Label

Neonates (less than or equal to 28 days of postnatal age) - Dosage should be based on Gestational age and Postnatal age according to Table 3 Table 3: Dosage in Neonates (less than or equal to 28 days of postnatal age) for Bacterial Meningitis and Septicemia: Gestational age (weeks) Postnatal age (days) Dosage less than or equal to 34 less than or equal to 7 100 mg/kg/day in equally divided doses every 12 hours less than or equal to 34 greater than or equal to 8 and less than 28 150 mg/kg/day in equally divided doses every 12 hours greater than 34 less than or equal to 28 150 mg/kg/day in equally divided doses every 8 hours

Ampicillin is used to cover meningitis in neonates (less than or equal to 28 days of postnatal age), with dosage based on gestational age and postnatal age. For adults and children, the dosage is 150 to 200 mg/kg/day in equally divided doses every 3 to 4 hours 2.

From the Research

Age Considerations for Ampicillin Use in Meningitis

• Ampicillin is used to cover meningitis in various age groups, but its effectiveness and recommended use can vary based on the patient's age and the causative pathogen of the meningitis.
• For neonates, ampicillin is recommended for initial empiric therapy of meningitis, often in combination with gentamicin or cefotaxime, due to the common causes of meningitis in this age group, such as group B streptococci and Escherichia coli 3.
• In children older than 3 months, ampicillin can be used to treat meningitis caused by susceptible organisms, but resistance patterns, especially among Haemophilus influenzae, must be considered 4, 5.
• The dosage of ampicillin may vary, but studies suggest that high-dosage regimens offer no significant benefit over low-dosage regimens in the treatment of bacterial meningitis 5.
• For infants and children, sulbactam/ampicillin has been compared to chloramphenicol/ampicillin for the treatment of meningitis, showing that sulbactam/ampicillin is as effective as chloramphenicol/ampicillin 6.

Pathogen Considerations

• The choice of ampicillin for meningitis treatment also depends on the suspected or confirmed pathogen, with ampicillin being preferred for group B streptococcal meningitis and Listeria monocytogenes meningitis 3.
• For gram-negative meningitis, ampicillin may be used in combination with an aminoglycoside or cefotaxime 3.

Conclusion is not allowed, so the response ends here.